| Literature DB >> 35925055 |
Maik von der Forst1, Benedict Morath2, Martina Schwald2, Markus A Weigand1, Felix C F Schmitt3.
Abstract
Within the approved indications direct oral anticoagulants (DOAC) are increasingly gaining acceptance instead of vitamin K antagonists (VKA). In the last 12 months 5 guidelines relevant to the perioperative management of DOACs have been updated. This article summarizes the current recommendations for the perioperative management of treatment with DOACs. The available substances and their pharmacological properties as well as the possibilities for specific laboratory diagnostics of the effect of DOAC are explained. Special focus is placed on anesthesiologically important aspects of substance-specific preoperative and postoperative intermission intervals, the procedure for neuraxial regional anesthesia and antagonization with specific antidotes in cases of life-threatening bleeding.Entities:
Keywords: Anesthesia, regional; Antidotes; Bleeding risk; Blood coagulation; Bridging
Mesh:
Substances:
Year: 2022 PMID: 35925055 DOI: 10.1007/s00101-022-01142-7
Source DB: PubMed Journal: Anaesthesiologie ISSN: 2731-6858